An oral developmental neurotoxicity study of decabromodiphenyl ether (DecaBDE) in rats

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 92, Issue 1, 2011, Pages 17-35

  Biesemeier, John A ^a   Beck, Melissa J ^b   Silberberg, Hanna ^c   Myers, Nicole R ^b   Ariano, John M ^a   Radovsky, Ann ^b   Freshwater, Les ^d   Sved, Daniel W ^b   Jacobi, Sylvia ^e   Stump, Donald G ^b   Hardy, Marcia L ^e   Stedeford, Todd ^e  

^a LANXESS DEUTSCHLAND GMBH   (Germany)

^b WIL RESEARCH LABORATORIES   (United States)

^c ICL IP America Inc   (United States)

^d BioSTAT Consultants   (United States)

^e Albemarle Corporation   (United States)

Author keywords

Brominated flame retardants; Exposure; Gestation; Lactation

Indexed keywords

CORN OIL; DECABROMODIPHENYL ETHER; FLAME RETARDANT; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BLOOD LEVEL; BODY GROWTH; BODY WEIGHT; BRAIN WEIGHT; CAUSE OF DEATH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DEVELOPMENTAL STAGE; DRUG SURVEILLANCE PROGRAM; FEEDING; FEMALE; FETUS; FOOD INTAKE; GESTATION PERIOD; GOOD LABORATORY PRACTICE; LEARNING; MALE; MARE; MEMORY; MORPHOMETRICS; MOTOR ACTIVITY; NEUROPATHOLOGY; NEUROTOXICITY; NEWBORN; NEWBORN DEATH; NEWBORN MORTALITY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; RAT; STARTLE REFLEX; WEANING; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; BRAIN; CROSSES, GENETIC; EMBRYONIC DEVELOPMENT; FEEDING BEHAVIOR; FEMALE; HALOGENATED DIPHENYL ETHERS; MALE; MEMORY; MOTOR ACTIVITY; NEUROTOXINS; ORGAN SIZE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; SURVIVAL ANALYSIS; SWIMMING; TOXICITY TESTS;

MUS; RATTUS; ZEA MAYS;

EID: 79751493930     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.20280     Document Type: Article

References (51)

1. Adams J, Buelke-Sam J, Kimmel CA, et al. 1985. Collaborative behavioral teratology study: protocol design and testing procedures. Neurobehav Toxicol Teratol 7:579-586.
2. Biel WC. 1940. Early age differences in maze performance in the albino rat. J Genetic Psychol 56:439-453.
3. Biesemeier J, Beck M, Silberberg H, et al. 2010. Effects of dose, administration route and/or vehicle on decabromodiphenyl ether (DecaBDE) concentrations in plasma of maternal, fetal and neonatal rats and in milk of maternal rats. Drug Metab Disposit 38:1648-1654.
4. Buelke-Sam J, Sullivan PA, Kimmel CA, Nelson CJ. 1984. Sex and strain differences in the developmental activity profile of the rat tested over clean vs home cage bedding. Dev Psychobiol 17:67-77.
5. Buelke-Sam J, Ali SF, Kimmel GL, et al. 1989. Postnatal function following prenatal reserpine exposure in rats: neurobehavioral toxicity. Neurotoxicol Teratol 11:515-522.
6. Clarke PB, Kumar R. 1983. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329-337.
7. Dunn OJ. 1964. Multiple comparisons using rank sums. Technometrics 6:241-252.
8. Dunnett CW. 1964. New tables for multiple comparisons with a control. Biometrics 20:482-491.
9. EC. 2006. Commission Regulation (EC) No 565/2006 of 6 April 2006 imposing testing and information requirements on the importers or manufacturers of certain priority substances in accordance with Council Regulation (EEC) No 793/93 on the evaluation and control of the risks of existing substances. OJ L99:3-5.
10. EPA. 1989. Good Laboratory Practice Standards, Toxic Substances Control Act. 40 CFR Part 792.
11. EPA. 1991. Guidelines for developmental toxicity risk assessment. EPA/600/FR-91/001:1-83.
12. EPA. 1998. Developmental Neurotoxicity Study. Health Effects Test Guidelines OPPTS 870.6300, EPA 712-C-98-239:1-12.
13. EPA. 1999. Neurotoxic Pesticides; Availability of Data Call-in Notice, U.S. Environmental Protection Agency.
14. Goodman JE. 2009. Neurodevelopmental effects of decabromodiphenyl ether (BDE-209) and implications for the reference dose. Regul Toxicol Pharmacol 54:91-104.
15. Hardy ML, Schroeder R, Biesemeier J, Manor O. 2002. Prenatal oral (gavage) developmental toxicity study of decabromodiphenyl oxide in rats. Int J Toxicol 21:83-91.
16. Hardy M, Banasik M, Stedeford T. 2009. Toxicology and human health assessment of decabromodiphenyl ether. Crit Rev Toxicol 39:1-44.
17. Henck JW. 2002. Testing and interpretation. In: Massaro EJ, editor. Handbook of neurotoxicology. Totowa, NJ: Humana Press, Inc. pp 1-56.
18. Holson RR, Freshwater L, Maurissen JPJ, et al. 2008. Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol 30:326-348.
19. Holson RR, Pearce B. 1992. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 14:221-228.
20. Johansson N, Viberg H, Fredriksson A, Eriksson P. 2008. Neonatal exposure to deca-brominated diphenyl ether (PBDE 209) causes dose-response changes in spontaneous behaviour and cholinergic susceptibility in adult mice. Neurotoxicology 29:911-919.
21. Kociba RJ, Frauson LO, Humiston CG, et al. 1975. Results of a two-year dietary feeding study with decabromodiphenyl oxide (DBDPO) in rats. J Fire Flammability/Combustion Toxicol 2:267-285.
22. Korenbrot CC, Huhtaniemi IT, Weiner RI. 1977. Preputial separation as an external sign of pubertal development in the male rat. Biol Reprod 17:298-303.
23. Kruskal WH, Wallis WA. 1952. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47:583-621.
24. Macphail RC, Farmer JD, Jarema KA, Chernoff N. 2005. Nicotine effects on the activity of mice exposed prenatally to the nicotinic agonist anatoxin-a. Neurotoxicol Teratol 27:593-598.
25. MacPhail RC, Farmer JD, Jarema KA. 2007. Effects of acute and weekly episodic exposures to anatoxin-a on the motor activity of rats: comparison with nicotine. Toxicology 234:83-89.
26. Menzaghi F, Whelan KT, Risbrough VB, et al. 1997. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats. J Pharmacol Exp Ther 280:384-392.
27. Miller DK, Wilkins LH, Bardo MT, et al. 2001. Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Psychopharmacology (Berl) 156:469-476.
28. Norris JM, Ehrmantraut JW, Gibbons CL, et al. 1973. Toxicological and environmental factors involved in the selection of decabromodiphenyl oxide as a fire retardant chemical. Appl Polym Symp 22:195-219.
29. Norris JM, Ehrmantraut JW, Gibbons CL, et al. 1974. Toxicological and environmental factors involved in the selection of decabromodiphenyl oxide as a fire retardant chemical. JFF/Combusion Toxicology 1:52-77.
30. Norris JM, Kociba RJ, Schwetz BA, et al. 1975. Toxicology of octabromobiphenyl and decabromodiphenyl oxide. Environ Health Perspect 11:153-161.
31. NRC. 2000. Decabromodiphenyl Oxide. Toxicological Risks of Selected Flame-Retardant Chemicals, Chapter 5. Washington, DC: National Academy Press. pp 72-98.
32. NTP. 1986. Toxicology and carcinogenesis studies of decabromodiphenyl oxide (CAS No. 1163-19-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). Technical Report Series No. 309:1-242.
33. O'Neill MF, Dourish CT, Iversen SD. 1991. Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology (Berl) 104:343-350.
34. OECD. 1997. Principles on Good Laboratory Practice. OECD[C(97)186/Final].
35. OECD. 2007. OECD guideline for the testing of chemicals. Developmental Neurotoxicity Study, Test Guideline 426:1-26.
36. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 4th Edition. New York: Academic Press.
37. Rice DC, Reeve EA, Herlihy A, et al. 2007. Developmental delays and locomotor activity in the C57BL6/J mouse following neonatal exposure to the fully-brominated PBDE, decabromodiphenyl ether. Neurotoxicol Teratol 29:511-520.
38. Rice DC, Thompson WD, Reeve EA, et al. 2009. Behavioral changes in aging but not young mice after neonatal exposure to the polybrominated flame retardant decaBDE. Environ Health Perspect 117:1903-1911.
39. Rinaldi PC, Thompson RF. 1985. Age, sex and strain comparison of habituation of the startle response in the rat. Physiol Behav 35:9-13.
40. Salewski E. 1964. Färbemethode zum makroskopischen Nachweis von Implantationsstellen am Uterus der Ratte [Staining method for a macroscopic test for implantation sites in the uterus of the rat]. Naunyn Schmiedebergs Arch Pharmacol 247:367.
41. SAS. 2002-2003. SAS Proprietary Software, Version 9.1. Version 9.1. Cary: SAS Institute, Inc.
42. Schwetz BA, Smith FA, Nitschke KD, et al. 1975. Results of a Reproduction Study in Rats maintained on Diets Containing Decabromodiphenyl Oxide. Midland: Dow Chemical, USA. pp 1-22.
43. Steel RGD, Torrie JH. 1980. Principles and procedures of statistics, a biometrical approach, 2nd Edition. New York: McGraw-Hill Book Company. pp 504-506.
44. Thompson RF, Spencer WA. 1966. Habituation: a model phenomenon for the study of neuronal substrates of behavior. Psychol Rev 73:16-43.
45. Viberg H. 2009. Exposure to polybrominated diphenyl ethers 203 and 206 during the neonatal brain growth spurt affects proteins important for normal neurodevelopment in mice. Toxicol Sci 109:306-311.
46. Viberg H, Fredriksson A, Jakobsson E, et al. 2003. Neurobehavioral derangements in adult mice receiving decabrominated diphenyl ether (PBDE 209) during a defined period of neonatal brain development. Toxicol Sci 76:112-120.
47. Viberg H, Johansson N, Fredriksson A, et al. 2006. Neonatal exposure to higher brominated diphenyl ethers, hepta-, octa-, or nonabromodiphenyl ether, impairs spontaneous behavior and learning and memory functions of adult mice. Toxicol Sci 92:211-218.
48. Viberg H, Fredriksson A, Eriksson P. 2007. Changes in spontaneous behaviour and altered response to nicotine in the adult rat, after neonatal exposure to the brominated flame retardant, decabrominated diphenyl ether (PBDE 209). Neurotoxicology 28:136-142.
49. Wagner VO, Klug ML. 1998. Bacterial Reverse Mutation Assay; Test Article: Decabromodiphenyl Oxide. Rockville: MA BioServices, Inc. Report nr G98AV87.503. 1-48p.
50. Williams AL, DeSesso JM. 2010. The potential of selected brominated flame retardants to affect neurological development. J Toxicol Environ Health B Crit Rev 13:411-448.
51. Xing T, Chen L, Tao Y, et al. 2009. Effects of decabrominated diphenyl ether (PBDE 209) exposure at different developmental periods on synaptic plasticity in the dentate gyrus of adult rats in vivo. Toxicol Sci 110:401-410.